Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahdi Barzegar

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|February 15, 2022
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysisMahdi Barzegar, Omid Mirmosayyeb, Narges Ebrahimi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
COVID-19 Among Patients With Multiple Sclerosis: A Systematic ReviewMahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.
Multiple Sclerosis and Related Disorders|January 1, 2023
Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosisFereshteh Ashtari, Navid Manouchehri, Vahid Shaygannejad, et al.
Multiple Sclerosis and Related Disorders|September 2, 2023
Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based studyMahdi Barzegar, Setayesh Sindarreh, Amirreza Manteghinejad, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2023
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysisSara Bagherieh, Alireza Afshari-Safavi, Saeed Vaheb, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 17, 2020
Omega 3 Supplementation Can Regulate Inflammatory States in Gas Station Workers: A Double-Blind Placebo-Controlled Clinical TrialShoresh Barkhordari, Omid Mirmosayyeb, Marjan Mansourian, et al.
Multiple Sclerosis and Related Disorders|February 15, 2024
Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based studyMahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis International|October 3, 2022
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-AnalysisMahdi Barzegar, Shakiba Houshi, Erfan Sadeghi, et al.
Basic and Clinical Neuroscience|December 20, 2021
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis OpticaMilad Moayednia, Leila Dehghani, Amir Safi, et al.
Multiple Sclerosis and Related Disorders|February 24, 2023
Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based studyMahdi Barzegar, Amirreza Manteghinejad, Alireza Afshari-Safavi, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|February 15, 2022
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysisMahdi Barzegar, Omid Mirmosayyeb, Narges Ebrahimi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
COVID-19 Among Patients With Multiple Sclerosis: A Systematic ReviewMahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.
Multiple Sclerosis and Related Disorders|January 1, 2023
Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosisFereshteh Ashtari, Navid Manouchehri, Vahid Shaygannejad, et al.
Multiple Sclerosis and Related Disorders|September 2, 2023
Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based studyMahdi Barzegar, Setayesh Sindarreh, Amirreza Manteghinejad, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2023
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysisSara Bagherieh, Alireza Afshari-Safavi, Saeed Vaheb, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 17, 2020
Omega 3 Supplementation Can Regulate Inflammatory States in Gas Station Workers: A Double-Blind Placebo-Controlled Clinical TrialShoresh Barkhordari, Omid Mirmosayyeb, Marjan Mansourian, et al.
Multiple Sclerosis and Related Disorders|February 15, 2024
Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based studyMahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis International|October 3, 2022
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-AnalysisMahdi Barzegar, Shakiba Houshi, Erfan Sadeghi, et al.
Basic and Clinical Neuroscience|December 20, 2021
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis OpticaMilad Moayednia, Leila Dehghani, Amir Safi, et al.
Multiple Sclerosis and Related Disorders|February 24, 2023
Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based studyMahdi Barzegar, Amirreza Manteghinejad, Alireza Afshari-Safavi, et al.
Pageof 5